Characteristic | Measure | No. of patientsa |
---|---|---|
Sex ratio | M:F | 208:39 |
Age (years) | Median (range) | 61.0 (25 to 87) |
BMI (kg/m2) | Median (range) | 22.8 (14.5 to 33.8) |
Preoperative Hb (g/L) | Median (range) | 135.0 (53 to 167) |
Preoperative Alb (g/L) | Mean ± SD | 40.9 ± 4.5 |
Preoperative Cr (μmol/L) | Median (range) | 76.0 (35 to 317) |
ECOG | 0 | 68 (27.6) |
 | 1 | 164 (66.4) |
 | 2 | 13 (5.3) |
 | 3 | 2 (0.8) |
Age-adjusted CCI | ≤4 | 76 (30.8) |
 | >4, <7 | 123 (49.8) |
 | ≥7 | 48 (19,4) |
Tumor grade | II | 23 (9.3) |
 | III | 224 (90.7) |
T stageb | Ta and Tis | 21 (8.5) |
 | T1 | 52 (21.0) |
 | T2 | 83 (33.5) |
 | T3 | 63 (25.4) |
 | T4 | 27 (10.9) |
N stageb | N0 | 198 (79.8) |
 | N1 | 17 (6.9) |
 | N2 | 26 (10.5) |
 | N3 | 6 (2.4) |
M stage | M0 | 242 (97.6) |
 | M1 | 5 (2.0) |
Urinary diversion | Orthotopic neobladder | 85 (34.3) |
 | Ileal conduit | 141 (57.1) |
 | Ureterocutaneostomy | 21 (8.5) |
Operation time | Median (range) | 5.15 (2.08 to 8.58) |
Hospital day | Median (range) | 20 (9 to 77) |